Sample size planning for phase II trials based on success probabilities for phase III

E-ISSN： 1539-1612|14|6|515-524

ISSN： 1539-1604

Source： PHARMACEUTICAL STATISTICS: THE JOURNAL OF APPLIED STATISTICS IN THE PHARMACEUTICAL INDUSTRY, Vol.14, Iss.6, 2015-11, pp. : 515-524

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bayesian methods for setting sample sizes and choosing allocation ratios in phase II clinical trials with time‐to‐event endpoints

STATISTICS IN MEDICINE, Vol. 34, Iss. 11, 2015-05 ,pp. : 1889-1903

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Bayesian dose‐finding design for phase I/II clinical trials with nonignorable dropouts

STATISTICS IN MEDICINE, Vol. 34, Iss. 10, 2015-05 ,pp. : 1721-1732

John Wiley & Sons Inc

Access to resources Recommend Favorite

Methods for proper handling of overrunning and underrunning in phase II designs for oncology trials

STATISTICS IN MEDICINE, Vol. 34, Iss. 13, 2015-06 ,pp. : 2128-2137

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II Multiple Linear Regression Profile with Small Sample Sizes

QUALITY AND RELIABILITY ENGINEERING INTERNATIONAL, Vol. 31, Iss. 5, 2015-07 ,pp. : 851-861

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adaptive sample size modification in clinical trials: start small then ask for more?

STATISTICS IN MEDICINE, Vol. 34, Iss. 29, 2015-12 ,pp. : 3793-3810

John Wiley & Sons Inc

Access to resources Recommend Favorite